Common Opioid Pain Relievers
Prescribed for At-Home Use (injectable opioids not included)
Click this image, below, for FDA-approved product Medication Guide, if available.
Click this image, below, for FDA-approved REMS (Risk Evaluation and Mitigation Strategy).
Short-Acting Opioids(Brand names are for products in the United States, other brands may be available elsewhere. All products are tablets or capsules unless otherwise indicated. APAP=acetaminophen - amount varies by product, check labels. Starting in January 2010 combination products in the U.S. may contain no more than 325 mg of APAP; however, this changeover may take several years.) |
|||
Opioid Ingredient |
Generic Available |
Brand Names (USA) |
Safety Notes |
Butorphanol |
butorphanol tartrate (nasal spray) |
Stadol NS (nasal spray) |
Sometimes prescribed for migraine headache but must not be overused. |
Codeine |
codeine |
|
Codeine products are weak opioids not advised for persons with kidney or liver disease. |
|
codeine + APAP |
Tylenol w/ codeine #3, Tylenol w/ codeine #4, and others |
Daily amount of acetaminophen from this and all other products must not total more than 4,000 mg. |
|
codeine + APAP + butalbital + caffeine |
Fioricet w/codeine |
The butalbital ingredient in these 2 products is a barbiturate with sedative (calming) effects. Do not use with alcohol or other sedatives. Products containing aspirin may not be safe if you have stomach bleeding or ulcers. |
codeine + aspirin + butalbital + caffeine |
Fiorinal w/codeine |
||
|
codeine + carisoprodol + aspirin |
Soma compound w/codeine |
The carisoprodol ingredient is a muscle relaxer (brand: Soma). |
|
codeine + phenylephrine + promethazine |
Prometh VC w/codeine |
The phenylephrine ingredient is a decongestant and promethazine (brand: Phenergan) is an antihistamine that help with nausea or vomiting. May cause drowsiness. |
|
codeine + promethazine |
|
Promethazine helps with nausea and vomiting. May cause drowsiness. |
|
codeine + pseudoephedrine + triprolidine |
Triacin-C |
Pseudoephedrine and triprolidine are decongestants (antihistamines) and may cause drowsiness. |
|
codeine + aspirin |
Empirin 3 (with codeine) |
|
Dihydrocodeine |
dihydrocodeine + APAP + caffeine |
Synalgos-DC
|
Daily amount of acetaminophen from this and all other products must not total more than 4,000 mg. Tell your prescriber if you have any stomach problems, such as bleeding or ulcers, before taking products containing aspirin. |
|
dihydrocodeine + aspirin + caffeine |
||
Fentanyl |
fentanyl (lozenge on a stick) |
|
Beginning in March 2012, all transmucosal immediate-release fentanyl (TIRF) products in the U.S. will have a single, shared REMS program, or TIRF REMS ACCESS. It will be available at: https://www.tirfremsaccess.com/ The Actiq lozenge looks like a "lollipop," so keep it safe from children and dispose of properly. |
|
fentany (buccal tablet) [approved 1/10/2011] |
|
Fentora tablets are held against inside of cheek (buccal area) until they are dissolved. [Approved January 2011.] |
|
<no generic> |
|
Onsolis film is applied to inside of cheek; it may be prescribed only for patients who are specially registered by their opioid prescribers. |
|
<no generic> |
|
Abstral is a fast-acting, rapidly dissolving tablet that is put under the tongue. Prescribers must be enrolled in a special REMS program. |
<no generic> |
This formulation of fentanyl is not equivalent to other fentanyl products administered for breakthrough pain. In Europe this product is known as PecFent (fentanyl pectin nasal spray). [FDA approved June 2011.] |
||
<no generic> |
The Subsys, individual-dose, disposable system is a liquid medicine for breakthrough cancer pain that is sprayed underneath the tongue (sublingual) and allowed to absorb. The amount of fentanyl in a dose of Subsys is not the same as the amount in other medicines containing fentanyl. [FDA approved January 2012.] |
||
Hydrocodone |
hydrocodone + APAP |
Anexsia, Co-Gesic, Lortab, Norco, Vicodin, Zydone |
Daily amount of acetaminophen from this and all other products must not be more than 4,000 mg. |
|
hydrocodone + ibuprofen |
Tell your prescriber if you have any stomach problems, such as bleeding or ulcers, before taking products containing ibuprofen. All hydrocodone combination products are expected to become Schedule II analgesics in the U.S. in winter 2013. |
|
Hydromorphone |
hydromorphone (liquid and tablets) |
Dilaudid (liquid and tablets) |
Strong opioid, 4 to 7 times more potent than morphine. |
Meperidine |
meperidine (syrup and tablets) |
Demerol (syrup and tablets) |
For short-term use only - 1 to 2 days. Not for use in patients with kidney or liver disease, or those who may experience seizures. |
Morphine |
morphine (solution and tablets) |
|
Sometimes labeled as morphine IR (immediate release) or morphine sulfate IR (MSIR). High doses used over time may cause nightmares or strange visions (hallucinations). |
Oxycodone |
oxycodone |
Percodan, Roxicodone, Endodan |
Oxecta (immediate-release oxycodone) applies special technology designed to discourage tampering. [FDA approved June 2011.] Daily amount of acetaminophen from oxycodone-APAP combination products and all other products must not total more than 4,000 mg.
|
<no generic> |
Oxecta |
||
|
oxycodone + APAP |
Oxycet, Percocet, Roxicet, Roxilox, Tylox, Endocet |
|
|
oxycodone + aspirin |
Percodan |
|
|
oxycodone + ibuprofen |
||
Oxymorphone |
oxymorphone |
Opana |
Similar to oxycodone but twice as strong. |
Pentazocine |
pentazocine + APAP |
Talacen |
Daily amount of acetaminophen from this and all other products must total more than 4,000 mg. Contains naloxone and can cause opioid withdrawal if not used properly. |
|
pentazocine + naloxone |
Talwin NX |
|
Propoxyphene (removed from U.S. market) |
propoxyphene |
Propoxyphene products (sometimes labeled dextropropoxyphene) are not advised for persons with kidney or liver disease, or in elderly patients. Daily amount of acetaminophen from this and all other products must not be more than 4,000 mg. |
|
|
propoxyphene + APAP |
||
Tapentadol |
<no generic> |
Be sure prescriber knows in advance if you are taking antidepressant medicines. |
|
Tramadol |
tramadol |
Ultram |
Be sure prescriber knows if you are taking antidepressant medicines. Daily amount of acetaminophen from this and all other products must not be more than 4,000 mg. |
|
tramadol + APAP |
Ultracet |
Long-Acting Opioids(All products are oral tablets or capsules unless otherwise indicated. ER=Extended Release, SR=Sustained Release. Brand names are for products in the United States, other brands may be available elsewhere.) |
|||
Opioid Ingredient |
Generic Available |
Brand Names (USA) |
Safety Notes |
Buprenorphine |
<no generic> |
Once-weekly patch is approved for moderate to severe pain. When transferring from existing opioid medicines to buprenorphine care must be taken to avoid opioid withdrawal symptoms. Buprenorphine sublingual products are pain-relievers only approved for opioid addiction treatment in the U.S. Suboxone also contains naloxone and may cause opioid withdrawal if the product is not used properly. |
|
|
|
Suboxone (sublingual tablet, and sublingual film) |
|
Fentanyl |
Fentanyl ER (patch) |
Do not apply more than one patch at a time unless directed otherwise; make sure patch is firmly attached; do not use with heat (e.g., heating pad, electric blanket, hot bath, etc.). |
|
Hydrocodone |
<no generic> |
FDA approved in October 2013, Zohydro is the first single-entity and extended-release hydrocodone product. |
|
Hydromorphone |
<no generic> |
This is a new product approved in 2010. Tablets must not be broken, chewed, or crushed. |
|
Levorphanol |
levorphanol |
Levo-Dromoran |
May last a long time in the body; follow directions for use carefully. |
Methadone |
methadone |
Dolophine, Methadose (liquid and tablets) |
A naturally long-acting opioid; started at a low dose and increased very gradually. Tell prescriber if you have any heart condition or liver disease. |
Morphine |
morphine ER |
Avinza, Kadian, MS Contin, Oramorph SR
|
Embeda contains extended-release morphine and naltrexone. Do not chew or crush, or use any alcohol while taking this drug. Embeda was temporarily recalled in spring 2011.
|
|
<no generic> |
||
Oxycodone |
oxycodone ER |
An improved formulation of this medicine was approved in 2010. |
|
Oxymorphone |
oxymorphone ER |
New, crush-resistant formulation of Opana ER approved in December 2011. Do not drink any alcohol when taking this product. |
|
Tapentadol |
<no generic> |
Nucynta was approved and added to this list in summer 2011. Be sure prescriber knows in advance if you are taking antidepressant medicines. |
|
Tramadol |
tramadol ER |
Ultram ER, Ryzolt |
Be sure prescriber knows in advance if you are taking antidepressant medicines. |
All brand names are trade marks - ® or ™ - of their respective manufacturers, and are presented above for information purposes only. Brand names are for products available in the United States; different brands may be available in other countries. |